438 related articles for article (PubMed ID: 26301494)
1. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas.
Nault JC; Datta S; Imbeaud S; Franconi A; Mallet M; Couchy G; Letouzé E; Pilati C; Verret B; Blanc JF; Balabaud C; Calderaro J; Laurent A; Letexier M; Bioulac-Sage P; Calvo F; Zucman-Rossi J
Nat Genet; 2015 Oct; 47(10):1187-93. PubMed ID: 26301494
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma.
Nault JC; Datta S; Imbeaud S; Franconi A; Zucman-Rossi J
Mol Cell Oncol; 2016 Mar; 3(2):e1095271. PubMed ID: 27308626
[TBL] [Abstract][Full Text] [Related]
3. Ccne1 Overexpression Causes Chromosome Instability in Liver Cells and Liver Tumor Development in Mice.
Aziz K; Limzerwala JF; Sturmlechner I; Hurley E; Zhang C; Jeganathan KB; Nelson G; Bronk S; Fierro Velasco RO; van Deursen EJ; O'Brien DR; Kocher JA; Youssef SA; van Ree JH; de Bruin A; van den Bos H; Spierings DCJ; Foijer F; van de Sluis B; Roberts LR; Gores GJ; Li H; van Deursen JM
Gastroenterology; 2019 Jul; 157(1):210-226.e12. PubMed ID: 30878468
[TBL] [Abstract][Full Text] [Related]
4. Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress.
Bayard Q; Meunier L; Peneau C; Renault V; Shinde J; Nault JC; Mami I; Couchy G; Amaddeo G; Tubacher E; Bacq D; Meyer V; La Bella T; Debaillon-Vesque A; Bioulac-Sage P; Seror O; Blanc JF; Calderaro J; Deleuze JF; Imbeaud S; Zucman-Rossi J; Letouzé E
Nat Commun; 2018 Dec; 9(1):5235. PubMed ID: 30531861
[TBL] [Abstract][Full Text] [Related]
5. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.
Sung WK; Zheng H; Li S; Chen R; Liu X; Li Y; Lee NP; Lee WH; Ariyaratne PN; Tennakoon C; Mulawadi FH; Wong KF; Liu AM; Poon RT; Fan ST; Chan KL; Gong Z; Hu Y; Lin Z; Wang G; Zhang Q; Barber TD; Chou WC; Aggarwal A; Hao K; Zhou W; Zhang C; Hardwick J; Buser C; Xu J; Kan Z; Dai H; Mao M; Reinhard C; Wang J; Luk JM
Nat Genet; 2012 May; 44(7):765-9. PubMed ID: 22634754
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus in the liver: natural history and consequences in tumour development.
La Bella T; Imbeaud S; Peneau C; Mami I; Datta S; Bayard Q; Caruso S; Hirsch TZ; Calderaro J; Morcrette G; Guettier C; Paradis V; Amaddeo G; Laurent A; Possenti L; Chiche L; Bioulac-Sage P; Blanc JF; Letouze E; Nault JC; Zucman-Rossi J
Gut; 2020 Apr; 69(4):737-747. PubMed ID: 31375600
[TBL] [Abstract][Full Text] [Related]
8. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas.
Murakami Y; Saigo K; Takashima H; Minami M; Okanoue T; Bréchot C; Paterlini-Bréchot P
Gut; 2005 Aug; 54(8):1162-8. PubMed ID: 16009689
[TBL] [Abstract][Full Text] [Related]
9. Novel pre-mRNA splicing of intronically integrated HBV generates oncogenic chimera in hepatocellular carcinoma.
Chiu YT; Wong JK; Choi SW; Sze KM; Ho DW; Chan LK; Lee JM; Man K; Cherny S; Yang WL; Wong CM; Sham PC; Ng IO
J Hepatol; 2016 Jun; 64(6):1256-64. PubMed ID: 26867494
[TBL] [Abstract][Full Text] [Related]
10. HIVID: an efficient method to detect HBV integration using low coverage sequencing.
Li W; Zeng X; Lee NP; Liu X; Chen S; Guo B; Yi S; Zhuang X; Chen F; Wang G; Poon RT; Fan ST; Mao M; Li Y; Li S; Wang J; Jianwang ; Xu X; Jiang H; Zhang X
Genomics; 2013 Oct; 102(4):338-44. PubMed ID: 23867110
[TBL] [Abstract][Full Text] [Related]
11. Integration of adeno-associated virus (AAV) into the genomes of most Thai and Mongolian liver cancer patients does not induce oncogenesis.
Schäffer AA; Dominguez DA; Chapman LM; Gertz EM; Budhu A; Forgues M; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Wu X; Bayarsaikhan E; Harris CC; Ruchirawat M; Ruppin E; Wang XW
BMC Genomics; 2021 Nov; 22(1):814. PubMed ID: 34763675
[TBL] [Abstract][Full Text] [Related]
12. Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations.
Toh ST; Jin Y; Liu L; Wang J; Babrzadeh F; Gharizadeh B; Ronaghi M; Toh HC; Chow PK; Chung AY; Ooi LL; Lee CG
Carcinogenesis; 2013 Apr; 34(4):787-98. PubMed ID: 23276797
[TBL] [Abstract][Full Text] [Related]
13. [Identification of HBx-related integration sites in HBsAg-positive hepatocellular carcinoma biopsy].
Zhu BH; Wang LT; Li T; Zhou BP
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):468-71. PubMed ID: 23044207
[TBL] [Abstract][Full Text] [Related]
14. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B].
Tu H; Gao HF; Ma GH; Liu Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
16. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma.
Wang J; Zindy F; Chenivesse X; Lamas E; Henglein B; Bréchot C
Oncogene; 1992 Aug; 7(8):1653-6. PubMed ID: 1321406
[TBL] [Abstract][Full Text] [Related]
17. AAV2 and Hepatocellular Carcinoma.
Nault JC; Datta S; Imbeaud S; Franconi A; Mallet M; Couchy G; Letouzé E; Pilati C; Verret B; Blanc JF; Balabaud C; Calderaro J; Laurent A; Letexier M; Bioulac-Sage P; Calvo F; Zucman-Rossi J
Hum Gene Ther; 2016 Mar; 27(3):211-3. PubMed ID: 26935016
[No Abstract] [Full Text] [Related]
18. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.
Minami M; Daimon Y; Mori K; Takashima H; Nakajima T; Itoh Y; Okanoue T
Oncogene; 2005 Jun; 24(27):4340-8. PubMed ID: 15806150
[TBL] [Abstract][Full Text] [Related]
19. Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients.
Park KJ; Lee J; Park JH; Joh JW; Kwon CH; Kim JW
Ann Lab Med; 2016 Sep; 36(5):469-74. PubMed ID: 27374713
[TBL] [Abstract][Full Text] [Related]
20. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
Ferber MJ; Montoya DP; Yu C; Aderca I; McGee A; Thorland EC; Nagorney DM; Gostout BS; Burgart LJ; Boix L; Bruix J; McMahon BJ; Cheung TH; Chung TK; Wong YF; Smith DI; Roberts LR
Oncogene; 2003 Jun; 22(24):3813-20. PubMed ID: 12802289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
